Company / Working Capital
Progyny Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$349.4M
FY2025
5-year range
$159.7M / $454.5M
FY2021-FY2025
Trend
+14.9%
vs FY2024
Sector context
#89 of 165
Health Care
What the data says
At $349M, Progyny's working capital ranks #89 of 165 in the Health Care sector. Declined from $454M to $349M over the past 2 years.
Based on SEC 10-K filings.
$349M in FY2025 with a 5-year CAGR of +25.5%.
Declined from $454M to $349M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +8.4%
- 5-Year CAGR
- +25.5%
- 10-Year CAGR
- -
Sector benchmark
#89 of 165 in Health CareTop 54% of 165This company $349.4M Sector average $836.2M
▼
-58.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.5%, indicating consistent growth.
- In FY2025, working capital increased 14.9% year-over-year.
- Ranks #89 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $349.4M | +14.9% |
| FY2024 | $304.1M | -33.1% |
| FY2023 | $454.5M | +65.7% |
| FY2022 | $274.3M | +71.8% |
| FY2021 | $159.7M | +42.0% |
| FY2020 | $112.4M | +16.8% |
| FY2019 | $96.3M | +1799.6% |
| FY2018 | -$5.7M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026